相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of elbasvir plus grazoprevir combination therapy in Japanese patients infected with hepatitis C virus genotype 1b
Yasue Takeuchi et al.
HEPATOLOGY RESEARCH (2019)
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1
Stefan Zeuzem et al.
HEPATOLOGY (2019)
Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study
Eiichi Ogawa et al.
HEPATOLOGY RESEARCH (2019)
EASL Recommendations on Treatment of Hepatitis C 2018
JOURNAL OF HEPATOLOGY (2018)
Short-Duration AL-335, Odalasvir, With or Without Simeprevir, in Patients With HCV GT1 or 3 Infection Without Cirrhosis
Edward J. Gane et al.
HEPATOLOGY (2018)
Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects
Matthew W. McClure et al.
PLOS ONE (2018)
Pharmacokinetics, safety, and tolerability of the 2- and 3-direct-acting antiviral combination of AL-335, odalasvir, and simeprevir in healthy subjects
Thomas N. Kakuda et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2018)
In vitro virology profile of the 3 direct-acting antiviral combination of AL-335, odalasvir and simeprevir
L. Vijgen et al.
JOURNAL OF HEPATOLOGY (2017)
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis
Paul Y. Kwo et al.
JOURNAL OF HEPATOLOGY (2017)
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
M. Bourliere et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment
Elise J. Smolders et al.
DRUG SAFETY (2016)
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
Jean-Michel Pawlotsky
GASTROENTEROLOGY (2016)
Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection
Stefan Zeuzem et al.
JOURNAL OF HEPATOLOGY (2016)
The importance of resistance to direct antiviral drugs in HCV infection in clinical practice
Christoph Sarrazin
JOURNAL OF HEPATOLOGY (2016)
Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need
Monique R. Bidell et al.
INFECTIOUS DISEASES AND THERAPY (2016)
Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies
Oliver Lenz et al.
JOURNAL OF HEPATOLOGY (2015)
Treatment of hepatitis C in difficult-to-treat patients
Peter Ferenci
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
J. J. Feld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-naive hepatitis C genotype 1-infected patients in Japan: the DRAGON study
Norio Hayashi et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Simeprevir with peginterferon/ribavirin for treatment-naive hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial
Norio Hayashi et al.
JOURNAL OF HEPATOLOGY (2014)
PRECLINICAL CHARACTERISTICS OF ACH-3102: A NOVEL HCV NS5A INHIBITOR WITH IMPROVED POTENCY AGAINST GENOTYPE-1A VIRUS AND VARIANTS RESISTANT TO 1ST GENERATION OF NS5A INHIBITORS
G. Yang et al.
JOURNAL OF HEPATOLOGY (2012)
Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase ha, open-label study
Christophe Moreno et al.
JOURNAL OF HEPATOLOGY (2012)
The Burden of Illness for Patients with Viral Hepatitis C: Evidence from a National Survey in Japan
Gordon G. Liu et al.
VALUE IN HEALTH (2012)
Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are decreased by alcohol
Masayoshi Yamada et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2011)
Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis
Nobuyuki Toshikuni et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
L Castéra et al.
GASTROENTEROLOGY (2005)
分享论文
